ZandCell Appoints Chief Medical Officer to Accelerate the Execution of International Medical Development Strategies
ZandCell Appoints Chief Medical Officer to Accelerate the Execution of International Medical Development Strategies Stockholm, SWEDEN, March 03, 2020 – ZandCell AB. (“ZandCell” or the “Company”), a biotechnology company focused on the development of therapies for untreatable diseases, is pleased to announce that Professor Doctor Panos Zavos has been appointed the Company’s Chief and Director … Continue reading